RVX 208   Click here for help

GtoPdb Ligand ID: 7034

Synonyms: QC-216 | RVX-000222 | RVX-208
PDB Ligand
Compound class: Synthetic organic
Comment: RVX 208 is a derivative of the plant polyphenol resveratrol. RVX 208 is an investigational antagonist of BET bromodomain containing proteins, with potential anti-atherosclerotic action for the treatment of cardiovascular disease (CVD) [2-3].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 2
Rotatable bonds 6
Topological polar surface area 93.67
Molecular weight 370.15
XLogP 3.86
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OCCOc1c(C)cc(cc1C)c1nc(=O)c2c([nH]1)cc(cc2OC)OC
Isomeric SMILES OCCOc1c(C)cc(cc1C)c1nc(=O)c2c([nH]1)cc(cc2OC)OC
InChI InChI=1S/C20H22N2O5/c1-11-7-13(8-12(2)18(11)27-6-5-23)19-21-15-9-14(25-3)10-16(26-4)17(15)20(24)22-19/h7-10,23H,5-6H2,1-4H3,(H,21,22,24)
InChI Key NETXMUIMUZJUTB-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
RVX 208 (under alternate research code RVX000222) reached Phase 2 clinical trial in patients with dyslipidemia and coronary artery disease [5].
Mechanism Of Action and Pharmacodynamic Effects Click here for help
RVX 208 appears to have similar anti-atherogenic properties to resveratrol [1,5].
RVX 208 binds in particular to the second bromodomain (BD2) of BET family member BRD4, which regulates ApoA-I expression through an epigenetic mechanism [3].
A phase I trial has indicated that RVX 208 may also have the ability to destroy β-amyloid plaques indicative of Alzheimer's disease (AD) [4].